Executive Team

David Sharples:CEO

Entrepreneur with successful track record with multiple start-up companies, experienced in recruiting and supervising strong management teams.

David Miles:COO

Commercial executive, previously Head of Inflammatory diseases, Europe at Pfizer. UK, EMEA and Global experience in emerging and established, biotech and pharmaceutical sectors, including pre-IPO. Demonstrable track record of building and leading commercial, access and medical teams to create and execute portfolio strategy.

Dr. Nicholas Larkins BVSc DSc MRCVS:CMO

Veterinarian with extensive research interests in pharmacognosy specifically focused on immunomodulatory phytochemicals and the roles they play in inflammation and the resolution of inflammation.

Alan Reynolds:CSO

Clinical Scientist with wide ranging experience across a number of therapeutic areas. Previously European Clinical Science Director Inflammation for Wyeth/Pfizer responsible for providing European input into global research and publication strategies and leading health economic submissions to NICE.

Wendy Richings Barrow:Regulatory

35 years experience in the pharma industry. Former Regulatory Affairs Manager, Lederle Laboratories before becoming Licensing & Acquisition Manager, Lederle Laboratories. Currently GM Subiaco Associates Ltd, Healthcare Regulatory Consultancy.

Nigel Brooksby:Strategy

Former Chairman and MD of Sanofi UK. 40 years experience in the pharma industry. He holds several Academic, Charity and Life Sciences Chairmanships and Senior Board positions, which include Porton Down, the Clinical Trials Unit at Imperial College London and advising the Wellcome Trust.